Invest in the future of MAIA Biotechnology
We are seeking investments to develop innovative cancer drugs to improve people’s lives.
MAIA is currently in the process of completing its Bridge Round of financing. Only a limited number of shares have been allocated to this round at the current pricing. Click the Contact Us button below for more information and indicate in your message that you are interested in the Bridge Round. This round will close upon the opening of the Series A round Fall of 2019.
MAIA will open availability to its Series A in the Fall of 2019. We are seeking to raise $21-27M. We have already begun making investor contacts and engaging in discussions. But there is ample time for other interested parties to engage in discussions with us. Click the Contact Us button below for more information and indicate in your message that you are interested in the Series A. We expect to close this round late Q4 2019 to Q1 2020.
Download company presentation here.Contact us